NETHERLANDS COMPOUNDING PHARMACIES MARKET ANALYSIS

Netherlands Compounding Pharmacies Market, By Product Type (Mouthwashes, Oral Medication (Capsule, Lollipops, Lozenges, Suspensions,Tablets), Suppositories Topical Medication (Cream, Gels, Lotions, Ointments)), By Application (Medication for Adults, Medication for Children, Medication for Geriatric, Medication for Veterinary), By Therapeutic Area (Hormone Replacement Therapy, Pain Management), By Facilities (Community Pharmacies, Hospitals) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published In : Dec 2019
Code : CMI3156
Pages :85
Formats :
Excel and PDF
Industry : Pharmaceutical

Netherlands Compounding Pharmacies MarketSize and Trends

Netherlands Compounding Pharmacies Market — Insights

The Netherlands compounding pharmacies market is estimated to account for US$ 520.5 Mn in terms of value by the end of 2027.

Oral medication held dominant position in the Netherlands compounding pharmacies market in 2018, accounting for 62.9% share in terms of value, followed by topical medication.

Medication of adults segment in the Netherlands compounding pharmacies market was valued at US$ 136.6 Mn in 2018 and is expected to reach US$ 287.8 Mn by 2027 at a CAGR of 8.6% during the forecast period.

Market Trends/Key Takeaways

The market is witnessing increasing preference for HRT drugs for indications such as menopausal symptoms, men’s health (andropause), and weight loss. However, untested ingredients, possibility of microbiological contaminations, errors in defining dosages of hormones and declining reimbursements from government are some of the factors that may hamper demand for HRT drugs in the Netherlands.

In the Netherlands, products are primarily purchased from specialized compounding companies and products from major market players are in high demand compared to those of community compounding pharmacies. Moreover, a majority of compounded drugs are outsourced to hospitals.